Related Experiment Video
Updated: Mar 14, 2026

06:21
Incorporating Pericytes into an Endothelial Cell Bead Sprouting Assay
Published on: February 16, 2018
8.8K
Endothelial Cells Require CD98 for Efficient Angiogenesis-Brief Report.
Zhongji Liao1, Joseph M Cantor2
1From the Department of Medicine, University of California San Diego, La Jolla.
Arteriosclerosis, Thrombosis, and Vascular Biology
|October 1, 2016
Summary
CD98 (also known as solute carrier 3A2) is crucial for endothelial cell (EC) growth and blood vessel formation. Targeting CD98 may offer a dual anticancer strategy by inhibiting tumor cell proliferation and angiogenesis.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- CD98 regulates integrin signaling and is essential for tumor cell proliferation.
- CD98 is expressed on endothelial cells (ECs), but its role in angiogenesis remains unclear.
Purpose of the Study:
- To investigate the function of CD98 in EC proliferation, blood vessel growth, and tumor angiogenesis.
- To determine the therapeutic potential of targeting CD98 in cancer.
Main Methods:
- Specific genetic targeting (EC-specific deletion of CD98 in mice).
- Antibody blockade of CD98.
- Analysis of tumor growth, retinal angiogenesis, and EC proliferation.
- Reconstitution experiments with CD98 mutants.
Main Results:
- CD98 is upregulated on angiogenic ECs.
- EC-specific deletion of CD98 inhibited tumor growth, retinal angiogenesis, and EC proliferation.
- The interaction between integrin and CD98 is essential for EC survival and growth.
- Anti-CD98 treatment inhibited vessel formation and reversed EC-assisted tumor growth.
Conclusions:
- CD98 is required for EC growth and angiogenesis.
- CD98-specific reagents demonstrate a dual anticancer effect by inhibiting tumor cell proliferation and angiogenesis.
- Targeting CD98 presents a promising therapeutic strategy for cancer treatment.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
3.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Mechanism of Angiogenesis
7.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.4K
Selectins
4.7K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
4.7K

